Caffeine: Dose, Timing, Half-Life and Performance Evidence

Caffeine is easy to recognize and surprisingly easy to compare badly.

A coffee, energy drink, pre-workout powder and caffeine tablet can all deliver the same active compound while presenting it in completely different products.

That makes the first useful specification simple:

How many milligrams of caffeine does the serving actually provide?

The next questions are harder.

How does that amount compare with doses studied for exercise? How quickly does caffeine reach the bloodstream? How long can it remain active? And when does a larger stimulant number stop being a useful product advantage?

Start with caffeine per serving

For supplement comparison, Bextera records the disclosed amount of caffeine in milligrams per serving.

The front of a pre-workout container might emphasize energy, focus or a “high-stim” formula, but those descriptions do not replace the actual caffeine amount.

A useful comparison should identify:

1. caffeine per full serving;
2. serving size;
3. number of servings;
4. other stimulant ingredients;
5. intended timing;
6. caffeine consumed from other sources during the same day.

This matters because caffeine exposure does not come only from supplements.

Coffee, tea, energy drinks, gels, medications and other products can contribute to the same daily total.

Caffeine from coffee and caffeine from a supplement are still caffeine

Caffeine is also known chemically as 1,3,7-trimethylxanthine.

The surrounding product can differ substantially, but the caffeine molecule does not become fundamentally different because it comes from coffee, an energy drink or a pre-workout powder.

That does not make every caffeine-containing product equivalent.

Coffee can contain other naturally occurring compounds. Pre-workout supplements can contain multiple active ingredients. Energy drinks can contain sugar or additional stimulants.

Those differences matter at the product level.

But claims that one source of ordinary caffeine is automatically a more advanced stimulant should be treated cautiously unless evidence demonstrates a meaningful difference.

Caffeine is absorbed quickly

The NIH Office of Dietary Supplements describes caffeine as rapidly absorbed and distributed throughout the body and brain.

Blood concentrations generally peak within about 45 minutes after consumption.

That helps explain why many exercise studies provide caffeine shortly before activity rather than several hours earlier.

It does not mean every person reaches the same concentration at exactly 45 minutes.

Food intake, formulation and individual metabolism can influence pharmacokinetics.

The useful point is broader:

caffeine is an acute stimulant with a relatively rapid onset, not a supplement that requires weeks of loading before it can affect performance.

Its half-life is much longer than its peak

Peak concentration and clearance are different concepts.

NIH describes caffeine’s typical half-life as approximately 4-5 hours.

A half-life is the time required for the amount of a substance in the body to fall by roughly half.

It does not mean caffeine suddenly disappears after four or five hours.

If someone consumes caffeine later in the day, a meaningful amount can remain in the body hours afterward.

That is one reason a product can improve alertness or an evening training session while still creating a sleep trade-off later.

Individual caffeine metabolism also varies, so a population-average half-life should not be interpreted as a personal stopwatch.

Exercise studies commonly use doses relative to body weight

Caffeine research often reports doses in milligrams per kilogram of body weight, written as mg/kg.

That makes studies involving people of different body sizes easier to compare.

NIH summarizes a substantial performance literature using approximately 2-6 mg/kg before exercise.

But this range should not be converted into an automatic personal dose.

Research ranges tell us what investigators studied.

They do not establish that everyone needs the same body-weight-adjusted amount or that the upper end is better.

This distinction has become even more important as newer research has examined lower doses.

A 2026 meta-analysis found benefits at relatively low doses

A 2026 systematic review and meta-analysis examined 48 randomized placebo-controlled studies involving 689 participants.

The analysis focused specifically on aerobic time-trial performance.

Researchers separated caffeine doses into:

• low: up to 3 mg/kg;
• moderate: 4-6 mg/kg;
• high: above 6 mg/kg.

Low doses of approximately 1.3-3 mg/kg improved time-trial performance compared with placebo.

Moderate doses of 4-6 mg/kg also improved performance and produced a more consistent ergogenic effect in that analysis.

No studies using doses above 6 mg/kg met the review’s eligibility requirements for its specific time-to-completion outcome.

That last point matters.

The review does not prove that every dose above 6 mg/kg is ineffective.

It means the researchers did not have eligible high-dose trials for that particular meta-analysis.

The practical takeaway is still useful:

a product does not need an extreme caffeine number to fall within ranges associated with performance effects.

Bextera’s pre-workout caffeine review examines that exercise evidence in more detail.

More caffeine is not automatically more effective

Supplement labels often encourage a simple comparison:

150 mg looks weaker than 250 mg.

250 mg looks weaker than 350 mg.

400 mg can therefore look like a premium specification.

Exercise evidence does not support using caffeine amount as a simple product-quality score.

Higher intake can increase the likelihood of:

• sleep disruption;
• restlessness;
• nausea;
• increased heart rate;
• anxiety;
• jitteriness;
• gastrointestinal discomfort.

The question is not simply whether a product contains “a lot” of caffeine.

It is whether the disclosed amount makes sense in the context of the intended use, the evidence and total caffeine exposure.

What does the FDA’s 400 mg figure actually mean?

The U.S. Food and Drug Administration cites 400 mg of caffeine per day as an amount not generally associated with negative effects for most adults.

That figure is frequently misunderstood.

It is not:

• a recommended daily caffeine target;
• a recommended pre-workout dose;
• proof that 400 mg at once is appropriate for everyone;
• a guarantee that an individual will have no side effects.

FDA specifically notes that sensitivity can vary according to factors such as body weight, medications, medical conditions and individual response.

The 400 mg figure is therefore best understood as a broad general reference for most adults.

It should not be turned into a performance prescription.

Timing has two sides

Caffeine is often discussed only in terms of when performance might improve.

NIH notes that exercise studies commonly use caffeine about 15-60 minutes before activity.

That gives timing a useful performance context.

But the same timing decision also has a second consequence:

sleep.

Because caffeine can remain in the body for hours, an evening pre-workout serving may affect much more than the workout itself.

Someone can experience an acute ergogenic effect and still create a recovery problem later if caffeine interferes with sleep.

That is why Bextera treats timing as part of the product specification rather than as a simple “take X minutes before exercise” rule.

Genetics may influence response, but the consumer story is not settled

Researchers have also investigated whether variants in the CYP1A2 gene help explain why people respond differently to caffeine.

A 2024 systematic review and meta-analysis found different pooled performance responses among CYP1A2 genotype groups.

But the authors also identified important reasons for caution.

Baseline differences and studies reporting conflicts of interest could have influenced the apparent genotype effect. After excluding studies with reported conflicts of interest, the genotype differences were no longer statistically clear.

That makes this an interesting research area rather than a reliable product-selection tool.

A consumer genetic result should not currently be treated as a guaranteed prescription for an “ideal” caffeine dose.

Habitual intake complicates comparison

Two people can consume the same amount of caffeine and describe very different experiences.

Regular caffeine intake can influence perceived stimulation and withdrawal symptoms.

Sleep status, anxiety sensitivity, body size, other stimulant exposure and individual metabolism can also change the practical response.

That is why a label number alone cannot tell us exactly how a product will feel.

For product analysis, Bextera records the measurable specification:

caffeine per serving.

Individual response belongs in the interpretation, not in a fake precision score.

Pure and highly concentrated caffeine deserves special caution

Ordinary caffeinated drinks and measured supplement servings should not be confused with bulk pure caffeine.

NIH and FDA have both warned about pure or highly concentrated caffeine products because very small measurement errors can produce dangerous exposures.

Pure caffeine powder is extremely potent.

That makes “cost per gram of caffeine” a poor consumer metric when applied to bulk caffeine products.

Bextera does not treat maximum concentration as a quality advantage.

For caffeine, accurate dosing is part of product safety.

How Bextera compares caffeine products

A useful caffeine comparison should answer at least seven questions:

1. How many milligrams of caffeine are present per serving?
2. Is that amount fully disclosed?
3. How large is the serving?
4. Does the product contain additional stimulants?
5. What is the intended use?
6. When is it intended to be consumed?
7. How does that serving fit into total caffeine exposure from the rest of the day?

For exercise products, an additional comparison can normalize caffeine by body weight because that is how much of the research literature reports exposure.

That calculation is useful for understanding studies.

It is not a recommendation that everyone calculate and consume a particular mg/kg target.

The takeaway

Caffeine is one of the better-supported performance ingredients, but that does not make caffeine comparison complicated.

Start with the amount actually supplied.

Then consider timing, total daily exposure, other stimulants and the purpose of the product.

Research supports performance effects at both relatively low and moderate doses, while higher numbers do not automatically mean larger benefits.

The FDA’s 400 mg/day reference should not be mistaken for a workout target, and caffeine’s roughly 4-5 hour half-life means an acute performance decision can still matter hours later.

For Bextera, the most useful caffeine label is therefore not the one with the biggest stimulant number.

It is the one that makes the dose clear enough to interpret against the evidence.